Clínica e Investigación en Arteriosclerosis (English Edition)
Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
LDL cholesterol as a causal agent of atherosclerosis
Juan Pedro-Botet; Elisenda Climent; David Benaiges;
Clin Investig Arterioscler. 2024;36 Supl 1:
Real-world characterization of clinical management and achievement of the recommended risk-based low-density lipoprotein cholesterol and blood pressure goals in patients with arterial hypertension and dyslipidemia. The SNAPSHOT study
Jose María Mostaza; Miquel Camafort Babkowksi; Soraya Sotto Rodriguez; Cristina Vehi Gasol; Juan Carlos Yáñez Wonenburguer; Miguel Chopo Alcubilla; Carlos Escobar; Maria Luisa Fernández Bujia; Fernando Gallo Trébol; Mar Gracia; Marta Martín Millán; Guillermo Pinillos; Juan Pedro Justel Pérez;
Clin Investig Arterioscler. 2026;38:
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study
Agustín Blanco Echevarría; Juan De Dios García Díaz; Assumpta Caixas; Núria Plana Gil; Miguel Ángel Rico Corral; Ian Bridges; Nafeesa Dhalwani; Sònia Gatell Menchen; Kausik K. Ray;
Clin Investig Arterioscler. 2023;35:263-71